Risultati della ricerca - Marc Ferrante

Raffina i risultati
  1. 1
    New biologics and small molecules in inflammatory bowel disease: an update

    New biologics and small molecules in inflammatory bowel disease: an update di João Sabino, Bram Verstockt, Séverine Vermeire, Marc Ferrante

    Pubblicazione 2019
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD

    Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD di Martina Poletti, Kaline Arnauts, Marc Ferrante, Tamás Korcsmáros

    Pubblicazione 2020
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    New treatment options for inflammatory bowel diseases

    New treatment options for inflammatory bowel diseases di Bram Verstockt, Marc Ferrante, Séverine Vermeire, Gert Van Assche

    Pubblicazione 2018
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?

    Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy? di Amelie Decock, Gert Van Assche, Séverine Vermeire, Wim Wuyts, Marc Ferrante

    Pubblicazione 2016
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  5. 5
    Therapeutic Drug Monitoring During Induction of Anti–Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

    Therapeutic Drug Monitoring During Induction of Anti–Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease di Konstantinos Papamichael, Niels Vande Casteele, Marc Ferrante, Ann Gils, Adam S. Cheifetz

    Pubblicazione 2017
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  6. 6
    Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors

    Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors di Tibor Hlavatý, Marc Ferrante, Liesbet Henckaerts, Rajaraman Eri, Paul Rutgeerts, Séverine Vermeire

    Pubblicazione 2006
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease

    Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease di Liesbet Henckaerts, Marieke Pierik, Marie Joossens, Marc Ferrante, P. Rutgeerts, Séverine Vermeire

    Pubblicazione 2007
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis

    Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis di Mette Julsgaard, Uma Mahadevan, Thea Vestergaard, Raf Mols, Marc Ferrante, Patrick Augustijns

    Pubblicazione 2023
    Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  9. 9
    Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease

    Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease di Triana Lobatón, Marc Ferrante, P. Rutgeerts, Vera Ballet, Gert Van Assche, Séverine Vermeire

    Pubblicazione 2015
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?

    Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs? di Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, Marc Ferrante, Isabel Spriet, Erwin Dreesen

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Ex Vivo Mimicking of Inflammation in Organoids Derived From Patients With Ulcerative Colitis

    Ex Vivo Mimicking of Inflammation in Organoids Derived From Patients With Ulcerative Colitis di Kaline Arnauts, Bram Verstockt, Anabela S. Ramalho, Séverine Vermeire, Catherine M. Verfaillie, Marc Ferrante

    Pubblicazione 2020
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding

    Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding di Sophie Restellini, Luc Biedermann, Petr Hrúz, Christian Mottet, Annick Moens, Marc Ferrante, Alain Schoepfer

    Pubblicazione 2020
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  13. 13
    Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis

    Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis di Padhmanand Sudhakar, Bram Verstockt, Jonathan Cremer, Sare Verstockt, João Sabino, Marc Ferrante, Séverine Vermeire

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience

    Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience di Thomas Billiet, Isabelle Cleynen, Vera Ballet, Marc Ferrante, Gert Van Assche, Ann Gils, Séverine Vermeire

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis

    Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis di David N. Moskovitz, Gert Van Assche, Benedikte Maenhout, Joris Arts, Marc Ferrante, Séverine Vermeire, Paul Rutgeerts

    Pubblicazione 2006
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease

    Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease di Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease

    Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease di Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire

    Pubblicazione 2019
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease

    DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease di Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire

    Pubblicazione 2021
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression

    Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression di Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire

    Pubblicazione 2022
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis

    Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis di Konstantinos Papamichael, Filip Baert, Sophie Tops, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire, Ann Gils, Marc Ferrante

    Pubblicazione 2016
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: